首頁 > 市場調查報告書 > 醫療設備

透析設備

市場調查報告書

商品編碼

1560823

全球腹膜透析市場 - 2024 - 2031

Global Peritoneal Dialysis Market - 2024 - 2031

出版日期: 2024年09月23日 | 出版商:

DataM Intelligence | 英文 186 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

報告概述

2023年全球腹膜透析市場規模達52億美元，預計2031年將達83億美元，2024-2031年預測期間複合年成長率為6.0%

腹膜透析是一種治療腎衰竭的方法，腎衰竭是腎臟無法有效過濾血液的情況。它涉及一種清潔液通過管道流入胃部區域或腹部，其中腹膜充當過濾器。經過設定的時間後，過濾後的液體將被丟棄。腹膜透析與血液透析不同，血液透析是在機器中將血液過濾到體外。治療可以在家中、工作或旅行時進行，但並非所有腎衰竭患者都能從這種治療中受益。成功的腹膜透析需要熟練的手部護理和值得信賴的護理人員。

市場動態：

驅動程式和限制

慢性腎臟病盛行率上升

全球 ESRD 和 CKD 發生率的上升是主要促進因素之一。隨著需要透析的患者數量的增加，對腹膜透析（PD）作為治療選擇的需求也在增加。

例如，根據 CDC 2023 報告，14% 的美國成年人（即 355 億人）患有慢性腎臟病 (CKD)。盛行率因年齡、種族和民族而異。 CKD 在 65 歲或以上人群 (34%)、非西班牙裔黑人成年人 (20%) 和女性 (14%) 中更為常見。它在非西班牙裔亞洲人或白人成年人中也更為普遍。

此外，2023 年 ISN-GKHA 報告估計，約有 8,500 億人受到 CKD 的影響。來自弱勢群體的人面臨更高的風險。

缺乏熟練的專業人員

腹膜透析（PD）設備的市場成長受到嚴格的政府法規、不斷增加的技術故障、疝氣和導管堵塞等併發症以及缺乏熟練專業人員的阻礙。此外，老年族群的接受度和認知度較低以及 PD 循環者的認知度較低也是促成因素。

細分市場分析

全球腹膜透析市場根據產品類型、治療類型、最終用戶和地區進行細分。

該產品類型細分市場的腹膜透析解決方案約佔腹膜透析市場佔有率的43.3%

此產品類型細分市場的腹膜透析溶液佔比約為43.3%。腹膜透析液（也稱為透析液）對於治療末期腎病 (ESRD) 或嚴重慢性腎病 (CKD) 患者至關重要。這些含有電解質、葡萄糖和其他滲透劑的液體會透過導管引入腹膜腔，作為半透過濾器。透析液的主要功能是從血液中吸收廢物、多餘的液體和毒素。溶液中葡萄糖的濃度顯著影響液體去除和廢物清除效率。

例如，2024 年3 月，印度醫療保健產業知名品牌、總部位於法裡達巴德的Mitra Industries 推出了最新創新產品——具有接近中性pH 值和低葡萄糖分解產物(GDP) 的三室腹膜透析(PD) 袋。這項突破性產品旨在徹底改變腹膜透析患者的照護方式，腹膜透析是慢性腎臟病 (CKD) 患者的重要療法。

市場地理分析

預計北美在整個預測期內將佔據總市場佔有率的 38.4% 左右

由於腎衰竭和慢性腎臟疾病的盛行率不斷增加，加上醫療保健成本的上升、政府的努力和可支配收入的增加，預計北美將在整個預測期內佔據約 38.4% 的總市場佔有率。。此外，糖尿病和肥胖會導致腎臟疾病。

例如，根據美國國家糖尿病和消化性腎病研究所的數據，超過七分之一的美國成年人（估計有370 億美國人）患有慢性腎病(CKD)。人來說，這是兩個最常見的原因腎臟疾病——CKD 的風險更大。近三分之一的糖尿病患者和五分之一的高血壓患者有腎臟疾病。

Peritoneal dialysis is a treatment for kidney failure, where the kidneys cannot filter blood effectively. It involves a cleansing fluid flowing through a tube into the stomach area, or abdomen, where the peritoneum acts as a filter. After a set time, the filtered fluid is discarded. Peritoneal dialysis differs from hemodialysis, which filters blood outside the body in a machine. Treatments can be done at home, work, or while traveling, but not everyone with kidney failure can benefit from this treatment. Skilled hand care and a trusted caregiver are required for successful peritoneal dialysis.

Market Dynamics: Drivers & Restraints

Rise in the prevalence of chronic kidney diseases

The rising incidence of ESRD and CKD worldwide is one of the primary drivers. As the number of patients requiring dialysis grows, the demand for peritoneal dialysis (PD) as a treatment option also increases.

For instance, according to the CDC 2023, reports that 14% of US adults, or 35.5 billion people, have chronic kidney disease (CKD). The prevalence varies by age, race, and ethnicity. CKD is more common in those aged 65 or older (34%), non-Hispanic Black adults (20%), and women (14%). It is also more prevalent in non-Hispanic Asian or White adults.

Moreover, the 2023 ISN-GKHA report estimates that approximately 850 billion people are affected by CKD. People from disadvantaged populations are at higher risk.

Lack of skilled professionals

The market growth of peritoneal dialysis (PD) devices is hindered by stringent government regulations, increasing technical failures, complications like hernias and catheter blockages, and a lack of skilled professionals. Additionally, low acceptance and awareness among the senior population and low awareness of PD cyclers are also contributing factors.

Market Segment Analysis

The global peritoneal dialysis market is segmented based on product type, treatment type, end user, and region.

The peritoneal dialysis solutions from the product type segment accounted for approximately 43.3% of the peritoneal dialysis market share

The peritoneal dialysis solutions from the product type segment accounted for approximately 43.3%. Peritoneal dialysis solutions, also known as dialysates, are essential in treating patients with end-stage renal disease (ESRD) or severe chronic kidney disease (CKD). These fluids, containing electrolytes, glucose, and other osmotic agents, are introduced into the peritoneal cavity through a catheter, acting as a semi-permeable filter. The primary function of the dialysis solution is to draw waste products, excess fluids, and toxins from the blood. The concentration of glucose in the solution significantly influences fluid removal and waste clearance efficiency.

For instance, in March 2024, Faridabad-based Mitra Industries, a renowned name in India's healthcare industry, unveiled its latest innovation- a triple-chambered peritoneal dialysis (PD) bag with a near-neutral pH and low glucose degradation products (GDPs). This groundbreaking product aims to revolutionize patient care for those undergoing peritoneal dialysis, a crucial therapy for Chronic Kidney Disease (CKD) patients.

Market Geographical Analysis

North America is estimated to hold about 38.4% of the total market share throughout the forecast period

North America is estimated to hold about 38.4% of the total market share throughout the forecast period due to the increasing prevalence of kidney failures and chronic kidney diseases, along with rising healthcare costs, government efforts, and disposable income, contribute to the growth of the industry. Additionally, diabetes and obesity contribute to kidney disorders.

For instance, according to National Institute of Diabetes and Digestive Kidney Diseases, Chronic kidney disease (CKD) affects more than 1 in 7 U.S. adults-an estimated 37 billion Americans.1 For Americans with diabetes or high blood pressure-the two most common causes of kidney disease-the risk for CKD is even greater. Nearly 1 in 3 people with diabetes and 1 in 5 people with high blood pressure have kidney disease.1 Other risk factors for developing kidney disease include heart disease and a family history of kidney failure.

Market Segmentation

By Product Type

Peritoneal Dialysis Solutions

Peritoneal Dialysis Machines

Peritoneal Dialysis Catheters

Dialysis Sets

Others

By Treatment Type

Automated Peritoneal Dialysis (APD)

Continuous Ambulatory Peritoneal Dialysis (CAPD)

By End User

Homecare Settings

Hospitals

Others

By Region

North America

U.S.

Canada

Mexico

Europe

Germany

France

Italy

Spain

Rest of Europe

South America

Brazil

Argentina

Rest of South America

Asia-Pacific

China

India

Japan

South Korea

Rest of Asia-Pacific

Middle East and Africa

Market Competitive Landscape

The major global players in the market include Baxter International Inc, Fresenius Medical Care AG & Co. KGaA, Medtronic plc, Nipro Corporation, DaVita Inc., Diaverum, B. Braun Melsungen AG, Asahi Kasei Corporation, Huaren Pharmaceutical, Co., Ltd, NxStage Medical, Inc among others.

Key Developments

In June 2023, AWAK Technologies (AWAK) and Singapore General Hospital (SGH) announced the launch of a pre-pivotal clinical trial with the enrolment of their first subject to study the safety and efficacy of an improved Automated Wearable Artificial Kidney Peritoneal Dialysis (AWAK PD) device. AWAK PD is a wearable and ultra-portable peritoneal dialysis (PD) system that allows patients with end-stage kidney disease to have dialysis on the go and has been granted 'Breakthrough Device Designation' by the US Food and Drug Administration (FDA).

Why Purchase the Report?

To visualize the global peritoneal dialysis market segmentation based on product type, treatment type, end user, and region as well as understand key commercial assets and players.

Identify commercial opportunities by analyzing trends and co-development.

Excel data sheet with numerous data points of the peritoneal dialysis market level with all segments.

PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.

Product mapping available as excel consisting of key products of all the major players.

The global peritoneal dialysis market report would provide approximately 64 tables, 61 figures, and 186 pages.

Target Audience 2024

Manufacturers/ Buyers

Industry Investors/Investment Bankers

Research Professionals

Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Product Type
3.2. Snippet by Treatment Type
3.3. Snippet by End User
3.4. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Rise in the prevalence of chronic kidney diseases
  - 4.1.1.2. Rise in the advancements of devices
- 4.1.2. Restraints
  - 4.1.2.1. Lack of skilled professionals
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Patent Analysis
5.6. PESTLE Analysis
5.7. SWOT Analysis
5.8. DMI Opinion

6. By Product Type

6.1. Introduction
- 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 6.1.2. Market Attractiveness Index, By Product Type
6.2. Peritoneal Dialysis Solutions*
- 6.2.1. Introduction
6.3. Peritoneal Dialysis Machines
6.4. Peritoneal Dialysis Catheters
6.5. Dialysis Sets
6.6. Others

7. By Treatment Type

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type
- 7.1.2. Market Attractiveness Index, By Treatment Type
7.2. Automated Peritoneal Dialysis (APD)*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Continuous Ambulatory Peritoneal Dialysis (CAPD)

8. By End User

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 8.1.2. Market Attractiveness Index, By End User
8.2. Homecare Settings*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Hospitals
8.4. Others

9. By Region

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 9.1.2. Market Attractiveness Index, By Region
9.2. North America
- 9.2.1. Introduction
- 9.2.2. Key Region-Specific Dynamics
- 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type
- 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.2.6.1. U.S.
  - 9.2.6.2. Canada
  - 9.2.6.3. Mexico
9.3. Europe
- 9.3.1. Introduction
- 9.3.2. Key Region-Specific Dynamics
- 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type
- 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.3.6.1. Germany
  - 9.3.6.2. UK
  - 9.3.6.3. France
  - 9.3.6.4. Italy
  - 9.3.6.5. Spain
  - 9.3.6.6. Rest of Europe
9.4. South America
- 9.4.1. Introduction
- 9.4.2. Key Region-Specific Dynamics
- 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type
- 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.4.6.1. Brazil
  - 9.4.6.2. Argentina
  - 9.4.6.3. Rest of South America
9.5. Asia-Pacific
- 9.5.1. Introduction
- 9.5.2. Key Region-Specific Dynamics
- 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type
- 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.5.6.1. China
  - 9.5.6.2. India
  - 9.5.6.3. Japan
  - 9.5.6.4. South Korea
  - 9.5.6.5. Rest of Asia-Pacific
9.6. Middle East and Africa
- 9.6.1. Introduction
- 9.6.2. Key Region-Specific Dynamics
- 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type
- 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

10. Competitive Landscape

10.1. Competitive Scenario
10.2. Market Positioning/Share Analysis
10.3. Mergers and Acquisitions Analysis

11. Company Profiles

11.1. Baxter International Inc*
- 11.1.1. Company Overview
- 11.1.2. Product Portfolio and Description
- 11.1.3. Financial Overview
- 11.1.4. Key Developments
11.2. Fresenius Medical Care AG & Co. KGaA
11.3. Medtronic plc
11.4. Nipro Corporation
11.5. DaVita Inc.
11.6. Diaverum
11.7. B. Braun Melsungen AG
11.8. Asahi Kasei Corporation
11.9. Huaren Pharmaceutical Co., Ltd.
11.10. NxStage Medical, Inc (*LIST NOT EXHAUSTIVE)